Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outbreak investigation for COVID-19 in northern Vietnam.
Thanh HN, Van TN, Thu HNT, Van BN, Thanh BD, Thu HPT, Kieu ANT, Viet NN, Marks GB, Fox GJ, Nguyen TA. Thanh HN, et al. Among authors: viet nn. Lancet Infect Dis. 2020 May;20(5):535-536. doi: 10.1016/S1473-3099(20)30159-6. Epub 2020 Mar 4. Lancet Infect Dis. 2020. PMID: 32145188 Free PMC article. No abstract available.
Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis.
Khan A, Zhang K, Singh VK, Mishra A, Kachroo P, Bing T, Won JH, Mani A, Papanna R, Mann LK, Ledezma-Campos E, Aguillon-Duran G, Canaday DH, David SA, Restrepo BI, Viet NN, Phan H, Graviss EA, Musser JM, Kaushal D, Gauduin MC, Jagannath C. Khan A, et al. Among authors: viet nn. Commun Biol. 2022 May 19;5(1):480. doi: 10.1038/s42003-022-03387-9. Commun Biol. 2022. PMID: 35590096 Free PMC article.
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.
De Castro N, Marcy O, Chazallon C, Messou E, Eholié S, N'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group. De Castro N, et al. Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2. Lancet Infect Dis. 2021. PMID: 33667406 Clinical Trial.